Rare outcomes, common treatments: analytic strategies using propensity scores

Editorial

Leonard E Braitman et al. Ann Intern Med. 2002.

. 2002 Oct 15;137(8):693-5.

doi: 10.7326/0003-4819-137-8-200210150-00015.

No abstract available

Comment in

Propensity scores for rare outcomes and common treatments.
Longstreth WT Jr, Fahrenbruch CE, Koepsell TD. Longstreth WT Jr, et al. Ann Intern Med. 2003 Jul 15;139(2):152-3. doi: 10.7326/0003-4819-139-2-200307150-00018. Ann Intern Med. 2003. PMID: 12859166 No abstract available.

Short-course rifampin and pyrazinamide compared with isoniazid for latent tuberculosis infection: a multicenter clinical trial.
Jasmer RM, Saukkonen JJ, Blumberg HM, Daley CL, Bernardo J, Vittinghoff E, King MD, Kawamura LM, Hopewell PC; Short-Course Rifampin and Pyrazinamide for Tuberculosis Infection (SCRIPT) Study Investigators. Jasmer RM, et al. Ann Intern Med. 2002 Oct 15;137(8):640-7. doi: 10.7326/0003-4819-137-8-200210150-00007. Ann Intern Med. 2002. PMID: 12379063 Clinical Trial.